Candriam Luxembourg S.C.A. »

Celldex Therapeutics shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2024-03-31 $13M 318k 41.97
2023-12-31 $13M 318k 39.66
2023-09-30 $8.9M 323k 27.52
2023-06-30 $19M 551k 33.93
2023-03-31 $20M 596k 33.12
2022-12-31 $22M 489k 44.57
2022-09-30 $12M 419k 28.11
2022-06-30 $7.8M 291k 26.96
2022-03-31 $9.5M 278k 34.06
2021-12-31 $15M 387k 38.64
2021-09-30 $9.7M 180k 53.99
2021-06-30 $13M 400k 33.44
2021-03-31 $5.8M 344k 16.83
2020-12-31 $6.0M 344k 17.52